Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker

Mads N Holten-Andersen; Ross W Stephens; Hans Jørgen Nielsen; Ib Jarle Christensen; Nils Brünner

Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker

Mads N Holten-Andersen (Inventor), Ross W Stephens (Inventor), Hans Jørgen Nielsen (Inventor), Ib Jarle Christensen (Inventor), Nils Brünner (Inventor)

Department of Clinical Medicine

Abstract

The present invention describes a method for determining whether an individual is likely to suffer from cancer by determining a parameter representing the TIMP-1 concentration in body fluid samples from the individual.

Original language	English
Patent number	7108983
Filing date	10/04/2000
Publication status	Published - 2000

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

http://www.google.com/patents?id=wwmVAAAAEBAJ&dq=Hvidovre+hospital

Cite this

@misc{b03ffb1870eb4f7985c0ea778b62e462,

title = "Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker",

abstract = "The present invention describes a method for determining whether an individual is likely to suffer from cancer by determining a parameter representing the TIMP-1 concentration in body fluid samples from the individual.",

author = "Holten-Andersen, {Mads N} and Stephens, {Ross W} and Nielsen, {Hans J{\o}rgen} and Christensen, {Ib Jarle} and Nils Br{\"u}nner",

note = "U.S. Classification 435/71; 435/723; 435/23; 530/350; 436/64; 436/501; 7108983",

year = "2000",

language = "English",

type = "Patent",

}

TY - PAT

T1 - Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker

AU - Holten-Andersen, Mads N

AU - Stephens, Ross W

AU - Nielsen, Hans Jørgen

AU - Christensen, Ib Jarle

AU - Brünner, Nils

N1 - U.S. Classification 435/71; 435/723; 435/23; 530/350; 436/64; 436/501

PY - 2000

Y1 - 2000

N2 - The present invention describes a method for determining whether an individual is likely to suffer from cancer by determining a parameter representing the TIMP-1 concentration in body fluid samples from the individual.

AB - The present invention describes a method for determining whether an individual is likely to suffer from cancer by determining a parameter representing the TIMP-1 concentration in body fluid samples from the individual.

M3 - Patent

M1 - 7108983

Y2 - 2000/04/10

ER -

Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this